Other languages Camurus AB

Equities

CAMX

SE0007692850

Market Closed - Nasdaq Stockholm Other stock markets 08:59:51 02/05/2024 pm IST			5-day change	1st Jan Change
494.4 ^SEK	-0.76%		+2.32%	-8.10%

17/04	Certain Shares of Camurus AB are subject to a Lock-Up Agreement Ending on 17-APR-2024.	CI
02/04	Camurus AB Announces Board Resignations	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Camurus AB Announces Board Resignations	02/04
Camurus' New Drug Application for Acromegaly Treatment Accepted by US FDA	05/03
Camurus AB Announces FDA Acceptance of NDA Submission for Oclaiz? for Treatment of Acromegaly	05/03
OPINIONES DE LOS ANALISTAS DEL DÍA : Acciona, Amadeus, Acs, Endesa, Ferrari, Heineken, Iberdrola, Prosegur, Salvatore Ferragamo...	04/03
AVIS D'ANALYSTES DU JOUR : Sanofi, Stellantis, Orange, STMicroelectronics, OVH, UCB, Valeo...	04/03
Camurus AB Reports Earnings Results for the Full Year Ended December 31, 2023	15/02
Camurus AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	15/02
Camurus AB Provides Earnings Guidance for the Full Year 2024	15/02
Camurus AB Appoints Behshad Sheldon as President of Camurus Inc. and Member of the it's Executive Management Team, Starting 1 April 2024	13/02
Camurus AB Completes Enrollment in the POSITANO Study of CAM2029 in Patients with Polycystic Liver Disease	08/02
Camurus Submits US FDA New Drug Application for Hormonal Disorder Treatment	21/12
Camurus AB Submits New Drug Application to the US FDA for Oclaiz for Treatment of Acromegaly	21/12
Camurus to Trade on Nasdaq Stockholm's Large Cap Segment	20/12
Camurus Concludes Enrollment in Phase 3 Study of Neuroendocrine Tumors Vaccine	14/12
Camurus AB Announces Completed Enrollment in the Phase 3 SORENTO Study of CAM2029 in Patients with Neuroendocrine Tumors	14/12
Camurus AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Camurus AB Raises Earnings Guidance for the Year 2023	23/23/23
Camurus Appoints Nomination Committee for the Annual General Meeting 2024	18/23/18
AVIS D'ANALYSTES DU JOUR : Alstom, Accor, Thales, Euroapi, LVMH, Ubisoft, Worldline, Pandora...	10/23/10
Camurus Launches Opioid Use Disorder Injection in US	05/23/05

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Camurus AB

Equities

CAMX

SE0007692850

Other languages

Filters